[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354684-105":59,"doc-detail-354684-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","multi-omic-cell-free-dna-profiles-of-cerebral-spinal-fluid-from-lung-cancer-metastasis-to-the-brain","Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain","","Cerebrospinal fluid (CSF) is a biological liquid bathing the brain and spinal canal. In patients with lung cancer brain metastasis, tumor cells release cell-free DNA (cfDNA) into CSF. Using nanopore single-molecule sequencing, the study characterizes DNA fragmentation, methylation, and hydroxymethylation patterns of CSF-derived cfDNA. Cancer samples show enriched mono-nucleosome levels and elevated mono-/trinucleosome ratios versus non-cancer controls. Distinct methylation and hydroxymethylation signatures further differentiate cancer from control CSF, including reduced hydroxymethylation and altered affected-gene pathway profiles.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omic-cell-free-dna-profiles-of-cerebral-spinal-fluid-from-lung-cancer-metastasis-to-the-brain/354684/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omic-cell-free-dna-profiles-of-cerebral-spinal-fluid-from-lung-cancer-metastasis-to-the-brain/354684.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main goal for CSF-derived cfDNA?","Question",{"text":113,"@type":114},"To profile CSF cfDNA from patients with lung cancer metastasis to the brain using nanopore sequencing, focusing on fragmentation, methylation, and hydroxymethylation patterns.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were cancer and control CSF samples compared?",{"text":118,"@type":114},"Cancer CSF cfDNA findings were compared with non-cancer healthy controls and their CSF cell-free DNA to identify distinguishing nucleosome, methylation, and hydroxymethylation features.",{"name":120,"@type":111,"acceptedAnswer":121},"What epigenetic differences were observed between cancer and non-cancer samples?",{"text":122,"@type":114},"Cancer CSF samples showed distinct methylation and hydroxymethylation patterns, including significantly lower hydroxymethylation in cancer patients versus healthy controls, with affected genes showing different pathway profiles.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354684,1790229886,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":14,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","NAR Cancer, 2026, 8, zcag021  \n[https://doi.org/10.1093/narcan/zcag021](https://doi.org/10.1093/narcan/zcag021)  \nCancer Gene Regulation, Chromatin, and Epigenetics  \nMulti-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain  \nTianqi Chen1 , Xiangqi Bai1 , Georgiana Burnside2 , Thy Trang Hoang Trinh2 , Melanie Hayden Gephart2 , Hanlee P. Ji 1,3 ,* , Billy T. Lau1 ,*  \n1 Division of Oncology, Department of Medicine, Stanford University, School of Medicine, Stanford, CA 94305, United States  \n2 Department of Neurosurgery, Stanford University, Stanford, CA 94305, United States  \n3 Department of Electrical Engineering, Stanford University, Stanford, CA 94305, United States  \n∗ To whom correspondence should be addressed. Email: [genomics_ji@stanford.edu](genomics_ji@stanford.edu)[ ](genomics_ji@stanford.edu)Correspondence may also be addressed to Billy T. Lau. Email: [billylau@stanford.edu](billylau@stanford.edu)  \nAbstract  \nCerebrospinal fluid (CSF) is a liquid biological medium immersing the brain and spinal canal. For patients with metastatic cancer from the lung, tumor cells release their cell-free DNA (cfDNA) into the CSF. We applied a nanopore single-molecule sequencing approach to analyze the fragmentation, methylation, and hydroxymethylation patterns present in CSF-derived cell-free DNA from patients with metastatic lung cancer to the brain. We compared the cancer cfDNA finding to non-cancer healthy controls and their CSF cell-free DNA. Among cancer patients, we observed enriched mono-nucleosome levels and significantly higher mono-/trinucleosome ratios in cancer patients. Comparison with plasmaderived cfDNA further confirmed the unique fragmentation features of CSF-derived cfDNA. Distinct methylation and hydroxymethylation patterns were observed between cancer and control CSF samples. We observed significantly lower degree of hydroxymethylation in cancer patients compared with healthy controls and the affected genes had different pathway profiles. Overall, CSF cfDNA in patients with non-small cell lung cancer brain metastases had distinct profiles of DNA fragmentation, methylation, and hydroxymethylation.  \nIntroduction  \nMalignancies like lung cancer, breast cancer, and melanoma frequently spread to the brain. Lung cancers have the highest risk for brain metastasis (BMET), with non-small cell lung cancer (NSCLC) accounting for 55% of BMET cases [1] . Approximately 10%–20% of NSCLC patients show metastases at diagnosis and over half will develop BMET during their clinical course [2, 3] . NSCLC patients with BMET have a particularly poor prognosis. The median overall survival at 29 months [4] . A common NSCLC genetic feature is somatic EGFR mutations, which are critical oncogenic drivers  \nin NSCLC [5] and indicative of a specific NSCLC molecular subtype. EGFR mutations are also associated with the presence of multiple metastatic sites, tumor recurrence, and a significantly higher risk of BMET [6] . Over 60% of metastatic  \nNSCLC patients with EGFR mutations have BMET [6] .  \nTumor cells release their DNA into the blood and other fluids. This analyte is called circulating tumor DNA (ctDNA) . The ctDNA is a typically small fraction of the total cell-free DNA (cfDNA) circulating in the blood and other body fluids. DNA sequencing of the cfDNA can identify the ctDNA fraction and reveal cancer-specific genomic features such as  \nReceived: March 6, 2026. Revised: June 21, 2026 . Accepted: August 3, 2026  \n© The Author(s) 2026 . Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [reprints@oup.com](reprints@oup.com) for","cbCaivxj686WdpOj","https://ap.wps.com/l/cbCaivxj686WdpOj","pdf",1472950,16,"English","# Abstract\n# Introduction","[{\"question\":\"What is the study’s main goal for CSF-derived cfDNA?\",\"answer\":\"To profile CSF cfDNA from patients with lung cancer metastasis to the brain using nanopore sequencing, focusing on fragmentation, methylation, and hydroxymethylation patterns.\"},{\"question\":\"How were cancer and control CSF samples compared?\",\"answer\":\"Cancer CSF cfDNA findings were compared with non-cancer healthy controls and their CSF cell-free DNA to identify distinguishing nucleosome, methylation, and hydroxymethylation features.\"},{\"question\":\"What epigenetic differences were observed between cancer and non-cancer samples?\",\"answer\":\"Cancer CSF samples showed distinct methylation and hydroxymethylation patterns, including significantly lower hydroxymethylation in cancer patients versus healthy controls, with affected genes showing different pathway profiles.\"}]","Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain | PDF",1790112977,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/4e6375ef200bbe1f47a7a7080bad604f.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/de969164e3b91b1e3ae3faa1260a2353.webp",982,1270]